Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil in Axillary Drainage After ALND for Breast Cancer
NCT02311543Phase 3Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Mar 2015
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tachosil in breast cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Mar 2015; status: completed.
02
Drugs
tachosil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02311543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311543.